SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-006211
Filing Date
2024-03-04
Accepted
2024-03-04 11:07:53
Documents
1
Period of Report
2023-09-20

Document Format Files

Seq Description Document Type Size
1 form4-03042024_040348.html 4  
1 form4-03042024_040348.xml 4 10206
  Complete submission text file 0001415889-24-006211.txt   11709
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE B221 #125 REDMOND WA 98053
Business Address
Morisset Valerie (Reporting) CIK: 0001868517 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40708 | Film No.: 24713396